These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7609744)

  • 1. [Therapy of systemic candidiasis].
    Meunier F
    Mycoses; 1994; 37 Suppl 2():52-5. PubMed ID: 7609744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal treatment in patients with cancer.
    Viscoli C; Castagnola E; Machetti M
    J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D; Nemet D
    Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.